» Articles » PMID: 12642175

Frontal Cortex BDNF Levels Correlate with Working Memory in an Animal Model of Down Syndrome

Overview
Journal Behav Brain Res
Date 2003 Mar 19
PMID 12642175
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Individuals with Down syndrome (DS) develop most neuropathological hallmarks of Alzheimer's disease early in life, including loss of cholinergic markers in the basal forebrain. Ts65Dn mice, an animal model of DS, perform poorly on tasks requiring spatial memory and also exhibit basal forebrain pathology beginning around 6 months of age. We evaluated memory as well as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) protein levels in basal forebrain, frontal cortex, hippocampus, and striatum in Ts65Dn mice at the age when cholinergic degeneration is first observed, and compared values to normosomic controls. Six-month-old Ts65Dn mice exhibited impairments in working and reference memory as assessed on a water radial-arm maze. The working memory deficit was related to the inability of Ts65Dn mice to successfully sustain performance as the working memory load increased. Coupled with cognitive performance deficiencies, Ts65Dn mice also exhibited lower frontal cortex BDNF protein levels than controls. Further, BDNF levels were negatively correlated with working memory errors during the latter portion of testing in Ts65Dn mice, thereby suggesting that lower BDNF protein levels in the frontal cortex may be associated with the observed working memory impairment.

Citing Articles

Longitudinal markers of cognitive procedural learning in fronto-striatal circuits and putative effects of a BDNF plasticity-related variant.

Geiger L, Wustenberg T, Zang Z, Melzer M, Witt S, Rietschel M NPJ Sci Learn. 2024; 9(1):72.

PMID: 39604428 PMC: 11603174. DOI: 10.1038/s41539-024-00282-2.


Toward the Identification of Neurophysiological Biomarkers for Alzheimer's Disease in Down Syndrome: A Potential Role for Cross-Frequency Phase-Amplitude Coupling Analysis.

Victorino D, Faber J, Pinheiro D, Scorza F, Almeida A, Costa A Aging Dis. 2023; 14(2):428-449.

PMID: 37008053 PMC: 10017148. DOI: 10.14336/AD.2022.0906.


Asynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome.

Li Z, Klein J, Rampam S, Kurzion R, Campbell N, Patel Y Front Neurosci. 2022; 16:932384.

PMID: 36161168 PMC: 9504873. DOI: 10.3389/fnins.2022.932384.


Rodent Modeling of Alzheimer's Disease in Down Syndrome: and Approaches.

Farrell C, Mumford P, Wiseman F Front Neurosci. 2022; 16:909669.

PMID: 35747206 PMC: 9209729. DOI: 10.3389/fnins.2022.909669.


Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone.

Valenti D, Stagni F, Emili M, Guidi S, Bartesaghi R, Vacca R Antioxidants (Basel). 2022; 11(1).

PMID: 35052567 PMC: 8773005. DOI: 10.3390/antiox11010062.